ABVC BioPharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $4.8M | $13.7M | $5.8M |
| FY2022 | $6.3M | $9.6M | $85.3K |
| FY2023 | $6.5M | $7.8M | $60.2K |
| FY2024 | $6.8M | $7.5M | $248.4K |
| FY2025 | $7.8M | $21.1M | $681.5K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $4.8M | $13.7M | $5.8M |
| FY2022 | $6.3M | $9.6M | $85.3K |
| FY2023 | $6.5M | $7.8M | $60.2K |
| FY2024 | $6.8M | $7.5M | $248.4K |
| FY2025 | $7.8M | $21.1M | $681.5K |